Tunable chemotherapy release using biocompatible fatty acid-modified ethyl cellulose nanofibers

Bibliographic Details
Title: Tunable chemotherapy release using biocompatible fatty acid-modified ethyl cellulose nanofibers
Authors: Michael Wildy, Qiangjun Hao, Wanying Wei, Duc Huy Nguyen, Kai Xu, John Schossig, Xiao Hu, David Salas-de la Cruz, Dong Choon Hyun, Zhihong Wang, Ping Lu
Source: Carbohydrate Polymer Technologies and Applications, Vol 9, Iss , Pp 100670- (2025)
Publisher Information: Elsevier, 2025.
Publication Year: 2025
Collection: LCC:Biochemistry
Subject Terms: Stimuli-responsive delivery, Ethyl cellulose nanofibers, Doxorubicin, Lauric acid, Phase change material, Electrospinning, Biochemistry, QD415-436
More Details: Localized stimuli-responsive delivery systems for chemotherapy drugs have the potential to revolutionize therapeutic outcomes by offering greater selectivity, thereby reducing systemic side effects and bolstering patient benefits. In this work, ethyl cellulose (EC) nanofibers were prepared using electrospinning, encapsulating both doxorubicin HCl (DOX) and Rhodamine B (RhB) as representative hydrophilic chemotherapy and model drugs, respectively, and lauric acid (LA) as a biocompatible phase change material (PCM). In vitro release profiles demonstrated a distinct temperature-dependent release pattern: a noteworthy 27 % increase in release for DOX at pH 7.4 at 40 °C compared to 37 °C after 96 h Additionally, the release mechanism of DOX showcased pronounced pH sensitivity, evidenced by an increase of 41 % in release after 96 h at pH 4 when the temperature was increased from 37 °C to 40 °C, combined with a noticeable reduction of burst release. Furthermore, cytotoxicity assay indicated the prolonged efficacy of the DOX-embedded nanofibers, underscoring their therapeutic potential. Advanced analytical techniques, such as DSC, XRD, and FTIR, revealed an amorphous state of the drugs and a harmonious PCM integration. Our EC drug delivery system (DDS) demonstrated potential for targeted, stimuli-responsive DOX release, which could revolutionize its traditional administration, particularly in post-surgical scenarios to prevent tumor recurrence.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2666-8939
Relation: http://www.sciencedirect.com/science/article/pii/S2666893925000106; https://doaj.org/toc/2666-8939
DOI: 10.1016/j.carpta.2025.100670
Access URL: https://doaj.org/article/3f0c0b94b82f4352b92831191d8588f1
Accession Number: edsdoj.3f0c0b94b82f4352b92831191d8588f1
Database: Directory of Open Access Journals
More Details
ISSN:26668939
DOI:10.1016/j.carpta.2025.100670
Published in:Carbohydrate Polymer Technologies and Applications
Language:English